Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A

Kristina Jonsson-Schmunk, Piynauch Wonganan, Jin Huk Choi, Shellie M. Callahan and Maria A. Croyle
Drug Metabolism and Disposition May 2016, 44 (5) 758-770; DOI: https://doi.org/10.1124/dmd.115.068874
Kristina Jonsson-Schmunk
Division of Pharmaceutics, College of Pharmacy (K.J.-S., P.W., J.H.C., S.M.C., M.A.C.), and Center for Infectious Disease (M.A.C.), The University of Texas at Austin, Austin, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Piynauch Wonganan
Division of Pharmaceutics, College of Pharmacy (K.J.-S., P.W., J.H.C., S.M.C., M.A.C.), and Center for Infectious Disease (M.A.C.), The University of Texas at Austin, Austin, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Huk Choi
Division of Pharmaceutics, College of Pharmacy (K.J.-S., P.W., J.H.C., S.M.C., M.A.C.), and Center for Infectious Disease (M.A.C.), The University of Texas at Austin, Austin, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shellie M. Callahan
Division of Pharmaceutics, College of Pharmacy (K.J.-S., P.W., J.H.C., S.M.C., M.A.C.), and Center for Infectious Disease (M.A.C.), The University of Texas at Austin, Austin, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria A. Croyle
Division of Pharmaceutics, College of Pharmacy (K.J.-S., P.W., J.H.C., S.M.C., M.A.C.), and Center for Infectious Disease (M.A.C.), The University of Texas at Austin, Austin, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Landmark studies describing the effect of microbial infection on the expression and activity of hepatic CYP3A used bacterial lipopolysaccharide as a model antigen. Our efforts to determine whether these findings were translatable to viral infections led us to observations suggesting that engagement of integrin receptors is key in the initiation of processes responsible for changes in hepatic CYP3A4 during infection and inflammation. Studies outlined in this article were designed to evaluate whether engagement of integrins, receptors commonly used by a variety of microbes to enter cellular targets, is vital in the regulation of CYP3A in the presence and absence of virus infection. Mice infected with a recombinant adenovirus (AdlacZ) experienced a 70% reduction in hepatic CYP3A catalytic activity. Infection with a mutant virus with integrin-binding arginine-glycine-aspartic acid (RGD) sequences deleted from the penton base protein of the virus capsid (AdΔRGD) did not alter CYP3A activity. CYP3A mRNA and protein levels in AdlacZ-treated animals were also suppressed, whereas those of mice given AdΔRGD were not significantly different from uninfected control mice. Silencing of the integrin β-subunit reverted adenovirus-mediated CYP3A4 suppression in vitro. Silencing of the α-subunit did not. Suppression of integrin subunits had a profound effect on nuclear receptors pregnane X receptor and constitutive androstane receptor, whereas retinoid X receptor α was largely unaffected. To our knowledge, this is the first time that extracellular receptors, like integrins, have been indicated in the regulation of CYP3A. This finding has several implications owing to the important role of integrins in normal physiologic process and in many disease states.

Footnotes

    • Received December 8, 2015.
    • Accepted February 10, 2016.
  • This research was supported by the National Institutes of Health National Institute of General Medical Sciences [Grant R21GM69870 (to M.A.C.)], the National Institutes of Health National Institute of Allergy and Infectious Diseases [Grant U01AI078045 (to M.A.C.)], and a University of Texas at Austin [James W. McGinity Graduate Fellowship and Williams and McGinity Graduate Fellowship (both to K.J.-S.)].

  • dx.doi.org/10.1124/dmd.115.068874.

  • Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 44 (5)
Drug Metabolism and Disposition
Vol. 44, Issue 5
1 May 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Integrins and Drug Metabolism

Kristina Jonsson-Schmunk, Piynauch Wonganan, Jin Huk Choi, Shellie M. Callahan and Maria A. Croyle
Drug Metabolism and Disposition May 1, 2016, 44 (5) 758-770; DOI: https://doi.org/10.1124/dmd.115.068874

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Integrins and Drug Metabolism

Kristina Jonsson-Schmunk, Piynauch Wonganan, Jin Huk Choi, Shellie M. Callahan and Maria A. Croyle
Drug Metabolism and Disposition May 1, 2016, 44 (5) 758-770; DOI: https://doi.org/10.1124/dmd.115.068874
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics